Forma Therapeutics Holdings, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported loss from operations of $44,058,000 against $26,939,000 a year ago. Net loss was $43,585,000 against $25,440,000 a year ago. Net loss per basic and diluted share was $0.92 against $4.58 a year ago. For the six months, the company reported loss from operations of $80,268,000 against $59,165,000 a year ago. Net loss was $79,545,000 against $14,210,000 a year ago. Net loss per basic and diluted share was $1.68 against $4.23 a year ago.